BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36893517)

  • 1. RNF130 protects against pulmonary fibrosis through suppressing aerobic glycolysis by mediating c-myc ubiquitination.
    Zhang J; Chen W; Du J; Chu L; Zhou Z; Zhong W; Liu D; Huang H; Huang Y; Qiao Y; Meng X; Zou F; Cai S; Dong H
    Int Immunopharmacol; 2023 Apr; 117():109985. PubMed ID: 36893517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
    Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
    Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
    Li X; Wang Y; Liang J; Bi Z; Ruan H; Cui Y; Ma L; Wei Y; Zhou B; Zhang L; Zhou H; Yang C
    Phytother Res; 2021 Oct; 35(10):5808-5822. PubMed ID: 34375009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.
    Pan J; Li Y; Wu X; Pan X; Liu C; Zhang H; Wang L; Jiang X; Wang J; Zang N; Pang L; Lv X
    J Ethnopharmacol; 2024 Mar; 322():117507. PubMed ID: 38122910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts.
    Lai X; Huang S; Lin Y; Qiu Y; Pu L; Lin S; Zeng Q; Huang W; Wang Z
    Int J Biol Macromol; 2023 Jan; 226():291-300. PubMed ID: 36481337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
    Guan R; Yuan L; Li J; Wang J; Li Z; Cai Z; Guo H; Fang Y; Lin R; Liu W; Wang L; Zheng Q; Xu J; Zhou Y; Qian J; Ding M; Luo J; Li Y; Yang K; Sun D; Yao H; He J; Lu W
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35777761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
    Ruan H; Luan J; Gao S; Li S; Jiang Q; Liu R; Liang Q; Zhang R; Zhang F; Li X; Zhou H; Yang C
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
    Gu S; Liang J; Zhang J; Liu Z; Miao Y; Wei Y; Li S; Gu J; Cui Y; Xiao T; Li X; Yang C
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.